Also, our in vitro studies show that the supernatant of Phd2-deficient BMDMs significantly increases the viability of a CRC cell line compared with WT BMDMs, providing additional evidence that Phd2 deficiency in TAMs contributes to augmented growth of Phd2+/– colitis-associated tumors. This evidence concerns the gene EGLN1 and colorectal carcinoma.